Chinese english Germany Japanese Korea

AS2863619

AS2863619 Struktur
2241300-51-4
CAS-Nr.
2241300-51-4
Englisch Name:
AS2863619
Synonyma:
AS2863619;Cyclin dependent kinase,AS2863619,STAT,AS 2863619,Inhibitor,inhibit,CDK,AS-2863619;4-(1-(2-Methyl-1H-benzo[d]imidazol-6-yl)-1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine dihydrochloride
CBNumber:
CB15821249
Summenformel:
C16H13ClN8O
Molgewicht:
368.79
MOL-Datei:
2241300-51-4.mol
Request For Quotation

AS2863619 Eigenschaften

storage temp. 
Store at -20°C
Löslichkeit
DMSO: 10 mM
Aggregatzustand
A solid

Sicherheit

AS2863619 Chemische Eigenschaften,Einsatz,Produktion Methoden

AS2863619 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

AS2863619 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 20)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ATK CHEMICAL COMPANY LIMITED 		+undefined-21-51877795
ivan@atkchemical.com China 32715 60
Nantong HI-FUTURE Biology Co., Ltd. 		+undefined18051384581
 sales@chemhifuture.com China 3136 58
TargetMol Chemicals Inc. 		+1-781-999-5354
support@targetmol.com United States 19973 58
Aladdin Scientific 		+1-+1(833)-552-7181
sales@aladdinsci.com United States 57511 58
Shanghai Chaolan Chemical Technology Center QQ:65489617 15618227136
 info@SuperLan-chem.com China 9824 58
Fan De(Beijing) Biotechnology Co., Ltd. 15911056312
 liming@bio-fount.com China 9730 58
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767
 sales@chemegen.com China 11289 58
Shanghai hongqu biomedical technology co. LTD 88888888888
 hongquchem@qq.com China 5132 58
cjbscvictory 13348960310 13348960310
 3003867561@qq.com China 10011 58
Nantong Hi-Future Biotechnology Co., Ltd 18051384581
 sales@chemhifuture.com China 3061 58
  • AS2863619
  • Cyclin dependent kinase,AS2863619,STAT,AS 2863619,Inhibitor,inhibit,CDK,AS-2863619
  • 4-(1-(2-Methyl-1H-benzo[d]imidazol-6-yl)-1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine dihydrochloride
  • 2241300-51-4
Copyright 2019 © ChemicalBook. All rights reserved